Crop Biolabs is participating on the internationalization program for NYC

Crop Biolabs was selected for the internationalization program “Land to Launch” for New York City (NYC), by SEBRAE and CNI (National Confederation of Industry). 

According to their business model, products, and target market, the program “Land to Launch” selected Brazilian companies with the potential to break into the North American market.

The Program 

The program “Land to Launch” is an initiative of SEBRAE and CNI, in partnership with Sosa, a global open innovation company, to accelerate the internationalization of Brazilian companies, supporting its potential to scale its solutions in the North American market.

During the program, the selected companies receive training, in contact with NYC, to launch and scale up products in the US market and substantiate approaches to the US market, in addition to direct contact with world-renowned accelerators. Sosa supports training and networking in the program. 

Among the participating companies, 7 will be selected for a more detailed on-site follow-up in NYC for their internationalization.

Participating in the Program has been a great opportunity to explore the opportunities of the financial market in NYC, the leading city in the global technological ecosystem and an excellent space for generating demand for the market. We are committed to this opportunity and our company’s internationalization”

Carolina Barizan, from the Crop Biolabs Revenue Office.

The Land to Launch program is a reference in the international market opening, bringing together companies with the most significant potential to generate business for the New York market or the entire North American market from New York.

Follow more details about Crop Biolabs’ participation in the program on our website and social media: https://cropbiolabs.com.br/ 

What is Crop

Crop is an integrated R&D laboratory specializing in preclinical efficacy and safety services, using alternative cell culture and molecular biology methodologies for the advanced therapeutics, pharmaceutical, cosmetic ingredients, and sanitizing industries.

Leave a Reply

Your email address will not be published. Required fields are marked *